TD Waterhouse Canada Inc. Purchases 890 Shares of Stryker Co. (NYSE:SYK)

TD Waterhouse Canada Inc. lifted its holdings in shares of Stryker Co. (NYSE:SYK - Free Report) by 0.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 121,239 shares of the medical technology company's stock after buying an additional 890 shares during the period. TD Waterhouse Canada Inc.'s holdings in Stryker were worth $43,657,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Stryker during the 4th quarter valued at approximately $25,000. Rakuten Securities Inc. lifted its stake in shares of Stryker by 618.2% in the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock valued at $28,000 after acquiring an additional 68 shares during the last quarter. Centricity Wealth Management LLC acquired a new position in Stryker in the 4th quarter worth about $30,000. BankPlus Trust Department acquired a new position in shares of Stryker in the fourth quarter valued at approximately $33,000. Finally, VSM Wealth Advisory LLC acquired a new position in shares of Stryker during the fourth quarter worth $36,000. 77.09% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, Director Allan C. Golston sold 2,458 shares of Stryker stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the transaction, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. This trade represents a 14.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Ronda E. Stryker sold 201,392 shares of the company's stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $392.24, for a total value of $78,993,998.08. Following the completion of the sale, the director now owns 3,642,075 shares in the company, valued at $1,428,567,498. The trade was a 5.24 % decrease in their position. The disclosure for this sale can be found here. 5.20% of the stock is owned by insiders.

Wall Street Analyst Weigh In

SYK has been the topic of several recent research reports. Royal Bank of Canada increased their price target on Stryker from $425.00 to $435.00 and gave the stock an "outperform" rating in a report on Wednesday, January 29th. BTIG Research set a $403.00 price objective on shares of Stryker and gave the company a "buy" rating in a research report on Monday, April 14th. Canaccord Genuity Group upped their target price on shares of Stryker from $420.00 to $435.00 and gave the stock a "buy" rating in a report on Wednesday, January 29th. Stifel Nicolaus raised their price target on shares of Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a report on Wednesday, January 29th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $442.00 price target on shares of Stryker in a research note on Friday, March 21st. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Stryker has an average rating of "Moderate Buy" and an average target price of $423.53.

Stryker Trading Up 1.1 %

NYSE:SYK traded up $3.83 during trading hours on Thursday, hitting $360.94. The company had a trading volume of 1,349,722 shares, compared to its average volume of 1,356,479. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The company has a market capitalization of $137.77 billion, a PE ratio of 46.51, a price-to-earnings-growth ratio of 2.93 and a beta of 0.93. The stock has a 50-day moving average price of $368.69 and a 200 day moving average price of $372.95.

Stryker (NYSE:SYK - Get Free Report) last announced its quarterly earnings results on Tuesday, January 28th. The medical technology company reported $4.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.87 by $0.14. Stryker had a net margin of 13.25% and a return on equity of 23.58%. During the same quarter in the previous year, the company earned $3.46 EPS. On average, equities research analysts predict that Stryker Co. will post 13.47 EPS for the current fiscal year.

Stryker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 30th. Investors of record on Monday, March 31st will be given a dividend of $0.84 per share. The ex-dividend date is Monday, March 31st. This represents a $3.36 annualized dividend and a dividend yield of 0.93%. Stryker's dividend payout ratio is presently 43.30%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.